From Scrappy to Scaled:

The Strategic Rise of Fractional CFOs

What to Expect

The role of today's finance executive is evolving—particularly in the life sciences industry, where companies must balance innovation, capital efficiency, and growth through every stage of development. As organizations increasingly turn to fractional and interim finance leaders, experienced CFOs and finance executives are finding new ways to deliver strategic impact without a traditional full-time role.

Join our Life Sciences/Pharma SIG meeting for a candid discussion on the rise of fractional finance leadership.

Hear perspectives from both a leading fractional CFO firm and experienced independent executives as they explore how finance leadership needs evolve from early-stage startups to scaling organizations, what it takes to build a successful fractional practice, and the opportunities shaping the future of senior finance leadership in life sciences and pharma.

Panelists: 

- Francisco Oliveira  - Managing Director CFGO, Finance Operations & Leadership for Life Science Innovators

 https://www.linkedin.com/in/franciscofoliveira/

- Darlene Deptula-Hicks  - Fractional CFO, Owner, Crimson Consulting, LLC

https://www.linkedin.com/in/darlenedeptulahicks/?skipRedirect=true

- Alex Salcedo - Interim/Fractional CFO, Meadowland Capital Management, Inc.

https://www.linkedin.com/in/alexsalcedo/ 

Moderators

- Marc Cote - Master Executive and Business Coach - FocalPoint 

https://www.linkedin.com/in/marc-r-cote/

- Geeta Singh - Co-chair Life Sciences/Pharma SIG, Managing Director/Principal GSi Advisory, EIR